Comorbidity and Fatality Among Covid Patients: A Hospital Based-Retrospective Cohort Study
DOI:
https://doi.org/10.26699/jnk.v10i2.ART.p210-216Keywords:
COVID-19, comorbidity, fatalityAbstract
People with comorbid diseases have a high risk of contracting COVID-19, because the immune system has decreased, thus increasing the risk of transmission of COVID-19 and even potentially increasing the risk of fatality. This study aimed to determine the comorbidity and mortality among COVID-19 confirmed cases during May to September, 2021. The study was a retrospective cohort with secondary data from the COVID-19 with in Hospital report from May to September, 2021, with a total sample of 178. We extracted demographic and clinical data, including hospital outcomes (discharge or death). The result of the research showed that the respondents separated in to two groups, half of them are patients with comorbidity (89 patients) and the rest are patients non comorbidity. From 89 patients with comorbidity, 62 % were died and 38 % were discharged. The most comorbidites were 67,4% diabetes mellitus, 33% hypertension. The fatality rate of COVID-19 patients was 34% devided to 61,8% were comorbidity patients and 5,5% were non comorbidity. The comorbidity related to fatality rate of COVID-19 patient’s (p=0.000). It is important for society to avoid and control comorbid factors of COVID-19References
Alfad, H., Saftarina, F., Kurniawan, B., 2020. Dampak Infeksi SARS-Cov-2 Terhadap Penderita Hipertensi. J. Major. 9, 181–185.
Bastug, A., Bodur, H., Erdogan, S., Gokcinar, D., Kazancioglu, S., Kosovali, B.D., Ozbay, B.O., Gok, G., Turan, I.O., Yilmaz, G., Gonen, C.C., Yilmaz, F.M., 2020. Clinical and laboratory features of COVID-19: Predictors of severe prognosis. Int. Immunopharmacol. 88, 106950. https://doi.org/10.1016/j.intimp.2020.106950
Drew, C., Adisasmita, A.C., 2020. Gejala dan komorbid yang memengaruhi mortalitas pasien positif COVID-19 di Jakarta Timur, Maret-September 2020 | Tarumanagara Medical Journal [WWW Document]. URL https://journal.untar.ac.id/index.php/tmj/article/view/11742 (accessed 7.5.23).
Ejaz, H., Alsrhani, A., Zafar, A., Javed, H., Junaid, K., Abdalla, A.E., Abosalif, K.O.A., Ahmed, Z., Younas, S., 2020. COVID-19 and comorbidities: Deleterious impact on infected patients. J. Infect. Public Health 13, 1833–1839. https://doi.org/10.1016/j.jiph.2020.07.014
Erener, S., 2020. Diabetes, infection risk and COVID-19 - PubMed [WWW Document]. URL https://pubmed.ncbi.nlm.nih.gov/32585364/ (accessed 7.5.23).
Fanani, A., 2020. HUBUNGAN FAKTOR RISIKO DENGAN KEJADIAN DIABETES MELLITUS. Julnal Keperawatan 12, 371–378. https://doi.org/doi.org/https://doi.org/10.32583/keperawatan.v12i3.763
Hussain, A., Bhowmik, B., do Vale Moreira, N.C., 2020. COVID-19 and diabetes: Knowledge in progress. Diabetes Res. Clin. Pract. 162, 108142. https://doi.org/10.1016/j.diabres.2020.108142
Kamyshnyi, A., Krynytska, I., Matskevych, V., Marushchak, M., Lushchak, O., 2020. Arterial Hypertension as a Risk Comorbidity Associated with COVID-19 Pathology. Int. J. Hypertens. 2020, 8019360. https://doi.org/10.1155/2020/8019360
Karya, K.W.S., Suwidnya, I.M., Wijaya, B.S., 2021a. Hubungan penyakit komorbiditas terhadap derajat klinis COVID-19. Intisari Sains Medis 12, 708–717. https://doi.org/10.15562/ism.v12i2.1143
Karya, K.W.S., Suwidnya, I.M., Wijaya, B.S., 2021b. Hubungan penyakit komorbiditas terhadap derajat klinis COVID-19. Intisari Sains Medis 12, 708–717. https://doi.org/10.15562/ism.v12i2.1143
Karyono, D.R., Wicaksana, A.L., 2020. Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. J. Community Empower. Health 3, 77–84. https://doi.org/10.22146/jcoemph.57325
Kemenkes, 2020. Pedoman Pencegahan dan Pengendalian COVID-19 [WWW Document]. URL https://covid19.kemkes.go.id/protokol-covid-19/kmk-no-hk-01-07-menkes-413-2020-ttg-pedoman-pencegahan-dan-pengendalian-covid-19/ (accessed 7.5.23).
Li, J., Liu, Z., Wu, G., Yi, M., Chen, Y., Li, K., Xu, X., Xiao, L., Wu, Q., Chen, J., Wu, X., 2020. D-Dimer as a Prognostic Indicator in Critically Ill Patients Hospitalized With COVID-19 in Leishenshan Hospital, Wuhan, China. Front. Pharmacol. 11, 600592. https://doi.org/10.3389/fphar.2020.600592
Lippi, G., Wong, J., Henry, B.M., 2020. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol. Arch. Intern. Med. 130, 304–309. https://doi.org/10.20452/pamw.15272
Long, H., Nie, L., Xiang, X., Li, H., Zhang, X., Fu, X., Ren, H., Liu, W., Wang, Q., Wu, Q., 2020. D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis. BioMed Res. Int. 2020, 6159720. https://doi.org/10.1155/2020/6159720
Longato, E., Fadini, G.P., Sparacino, G., Gubian, L., Di Camillo, B., 2020. Prediction of Cardiovascular Complications in Diabetes from Pharmacy Administrative Claims. pp. 315–320. https://doi.org/10.1109/MELECON48756.2020.9140600
Masruroh, 2018. HUBUNGAN UMUR DAN STATUS GIZI DENGAN KADAR GULA DARAH PENDERITA DIABETES MELITUS TIPE II. J. Ilmu Kesehat. Masy. 6, 153–163.
Nabila, T., 2021. SKRIPSI LITERATURE REVIEW : HIPERTENSI SEBAGAI KOMORBID PADA PASIEN COVID-19.
Perkeni, 2021. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia 2021. PERKENI.
Rahayu, L.A.D., Admiyanti, J.C., Khalda, Y.I., 2021. HYPERTENSION, DIABETES MELLITUS, AND OBESITY AS THE MAIN COMORBIDITY FACTORS OF MORTALITY IN COVID-19 PATIENTS: A LITERATURE REVIEW | JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia [WWW Document]. URL https://bapin-ismki.e-journal.id/jimki/article/view/342 (accessed 7.5.23).
Rias, Y.A., 2017. HUBUNGAN ANTARA BERAT BADAN DENGAN KADAR GULA DARAH ACAK PADA TIKUS DIABETES MELLITUS. J. Wiyata 4, 72–77.
Shi, Q., Zhang, Xiaoyi, Jiang, F., Zhang, Xuanzhe, Hu, N., Bimu, C., Feng, J., Yan, S., Guan, Y., Xu, D., He, G., Chen, C., Xiong, X., Liu, L., Li, H., Tao, J., Peng, Z., Wang, W., 2020. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study. Diabetes Care 43, 1382–1391. https://doi.org/10.2337/dc20-0598
Singh, A.K., Gupta, R., Ghosh, A., Misra, A., 2020. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab. Syndr. 14, 303–310. https://doi.org/10.1016/j.dsx.2020.04.004
Wang, 2020. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. BMC 24. https://doi.org/10.1186/s13054-020-02895-6
Wulandari, E.W., Ronoatmodjo, S., Salama, N., 2021. Hubungan Komorbid Hipertensi dengan Kematian pada Kasus Konfirmasi COVID-19 di DKI Jakarta, Maret-Agustus 2020. J. Ilmu Kesehat. Masy. 10, 287–298. https://doi.org/10.33221/jikm.v10i04.1026
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., Cao, B., 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet Lond. Engl. 395, 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3
